Skip to main content

Volume 17 - Issue 8 - August, 2005

Feature

Case Report
08/01/2008
The X-Sizer® (ev3, Inc., Plymouth, Minnesota) is a novel thrombectomy device that effectively removes intracoronary thrombus. Recent studies suggest that pre-treatment with the X-Sizer before percutaneous coronary intervention (PCI) in a...
The X-Sizer® (ev3, Inc., Plymouth, Minnesota) is a novel thrombectomy device that effectively removes intracoronary thrombus. Recent studies suggest that pre-treatment with the X-Sizer before percutaneous coronary intervention (PCI) in a...
The X-Sizer® (ev3, Inc.,...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Coronary artery perforation is a rare but serious complication of percutaneous coronary intervention (PCI). The incidence is 0.1% with lesions treated by balloon angioplasty and 0.5–3.0% with lesions treated by atheroablative devices.1 It can...
Coronary artery perforation is a rare but serious complication of percutaneous coronary intervention (PCI). The incidence is 0.1% with lesions treated by balloon angioplasty and 0.5–3.0% with lesions treated by atheroablative devices.1 It can...
Coronary artery perforation is a...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
Several studies have determined the safety and efficacy of percutaneous mitral valvuloplasty (PMV) during pregnancy, the larger series being those recently described by Esteves,122 Nercolini et al.,118 and Ben Farhat et al.120 Retrospectively...
Several studies have determined the safety and efficacy of percutaneous mitral valvuloplasty (PMV) during pregnancy, the larger series being those recently described by Esteves,122 Nercolini et al.,118 and Ben Farhat et al.120 Retrospectively...
Several studies have determined...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Barry George: Needless to say, Fayaz, you have a bias against distal protection, and it’s an emotional issue for those of us who do carotid stenting. Fayaz Shawl: I am not biased, I just think a randomized trial is needed. Barry George: I...
Barry George: Needless to say, Fayaz, you have a bias against distal protection, and it’s an emotional issue for those of us who do carotid stenting. Fayaz Shawl: I am not biased, I just think a randomized trial is needed. Barry George: I...
Barry George: Needless to say,...
08/01/2008
Journal of Invasive Cardiology
Vascular Disease
08/01/2008
Women with coronary artery disease (CAD) are known to have a higher prevalence of co-morbidities than men, including advanced age, hypertension, diabetes and concomitant non-cardiac disease. Female gender has been shown to be an independent...
Women with coronary artery disease (CAD) are known to have a higher prevalence of co-morbidities than men, including advanced age, hypertension, diabetes and concomitant non-cardiac disease. Female gender has been shown to be an independent...
Women with coronary artery...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
08/01/2008
Case Presentation. A 65-year-old gentleman, who works as a professional football referee, presented with progressive symptoms of angina. His job officiating games necessitated significant physical activity and endurance. He presented 10 days...
Case Presentation. A 65-year-old gentleman, who works as a professional football referee, presented with progressive symptoms of angina. His job officiating games necessitated significant physical activity and endurance. He presented 10 days...
Case Presentation. A 65-year-old...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
It is estimated that as many as 20% of Americans ? 65 years old and 50% ? 75 years old have peripheral arterial disease (PAD), a total approaching 14–16 million Americans.1-4 With our rapidly increasing elderly population, it is likely that...
It is estimated that as many as 20% of Americans ? 65 years old and 50% ? 75 years old have peripheral arterial disease (PAD), a total approaching 14–16 million Americans.1-4 With our rapidly increasing elderly population, it is likely that...
It is estimated that as many as...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
A major advance in the use of heparin has been the development of low-molecular weight heparins (LMWH), which inhibit both the action (anti-IIa effect) and the generation (anti-Xa effect) of thrombin.1,2 Because of their ease of...
A major advance in the use of heparin has been the development of low-molecular weight heparins (LMWH), which inhibit both the action (anti-IIa effect) and the generation (anti-Xa effect) of thrombin.1,2 Because of their ease of...
A major advance in the use of...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Primary percutaneous transluminal coronary angioplasty (PTCA) has been consistently demonstrated to be superior to thrombolytic therapy and is currently the recommended therapy for myocardial infarction (MI).1 However, no-reflow phenomenon...
Primary percutaneous transluminal coronary angioplasty (PTCA) has been consistently demonstrated to be superior to thrombolytic therapy and is currently the recommended therapy for myocardial infarction (MI).1 However, no-reflow phenomenon...
Primary percutaneous...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
08/01/2008
Stent placement in coronary arteries larger than 3 mm in diameter has been proven to be superior to conventional balloon angioplasty (PTCA) in reducing the risk of restenosis and major adverse cardiac events (MACE). Subsequent improvements in...
Stent placement in coronary arteries larger than 3 mm in diameter has been proven to be superior to conventional balloon angioplasty (PTCA) in reducing the risk of restenosis and major adverse cardiac events (MACE). Subsequent improvements in...
Stent placement in coronary...
08/01/2008
Journal of Invasive Cardiology